UnitedHealth Group (UNH)
481.11
-4.93 (-1.01%)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services
The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone.
Previous Close | 486.04 |
---|---|
Open | 483.14 |
Bid | 481.25 |
Ask | 483.99 |
Day's Range | 478.82 - 487.60 |
52 Week Range | 436.38 - 630.73 |
Volume | 3,680,792 |
Market Cap | 440.22B |
PE Ratio (TTM) | 31.04 |
EPS (TTM) | 15.5 |
Dividend & Yield | 8.400 (1.75%) |
1 Month Average Volume | 5,710,590 |
News & Press Releases

AM Best has affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) and the Long- and Short-Term Issuer Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. Concurrently, AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) is stable. (See link below for a detailed listing of the companies and ratings.)
By AM Best · Via Business Wire · March 12, 2025

Vanguard has some excellent dividend ETFs, but they are right for different investors.
Via The Motley Fool · March 11, 2025

Via Benzinga · February 25, 2025

NEW YORK, March 09, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSEUNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
By The Rosen Law Firm PA · Via GlobeNewswire · March 9, 2025

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
Via Benzinga · March 7, 2025

Two of the Dow Jones Industrial Average's 30 components make for no-brainer buys, while another brand-name member continues to suffer from self-inflicted wounds.
Via The Motley Fool · March 6, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSEMOH) and its peers.
Via StockStory · March 5, 2025

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSEUNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
By The Rosen Law Firm PA · Via GlobeNewswire · March 5, 2025

A Special Master has recommended dismissing the government's False Claims Act case against UnitedHealth, citing insufficient evidence. The government has 14 days to object.
Via Benzinga · March 5, 2025

Large cap biopharma and MedTech stocks are leading the healthcare sector higher.
Via Talk Markets · March 4, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSEUNH) and its peers.
Via StockStory · March 4, 2025

Via The Motley Fool · March 3, 2025

Via The Motley Fool · March 2, 2025

NEW YORK, March 02, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSEUNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
By The Rosen Law Firm PA · Via GlobeNewswire · March 2, 2025

Despite their impressive performance over the past decade, three of the biggest wealth-creating stocks are still considered undervalued.
Via Benzinga · March 2, 2025

Stocks tried to stage a weak rally to close the week but the short-term outlook will continue to be dictated by the uncertainty that is creating volatility
Via MarketBeat · March 1, 2025

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 27, 2025

Via Benzinga · February 27, 2025

Via The Motley Fool · February 26, 2025

Shares of major healthcare companies such as The Cigna Group Inc. (NYSECI), Molina Healthcare Inc. NYSE: MOHNYSEMOH)(NYSE: UNHNYSEUNH dropped Wednesday following the signing of an executive order by President Donald Trump aimed at strengthening price transparency regulations in the industry.
Via Benzinga · February 26, 2025

Via Benzinga · February 26, 2025

UnitedHealth Group Inc. (NYSEUNH) shares are trading lower Tuesday after the Wall Street Journal reported that Senator Chuck Grassley launched an inquiry into the company's Medicare billing practices.
Via Benzinga · February 25, 2025

UnitedHealthcare will stop covering Myriad Genetics' GeneSight test in 2025, impacting $45 million in revenue. Myriad reaffirms guidance and names a new CEO.
Via Benzinga · February 25, 2025